γδ T cells: origin and fate, subsets, diseases and immunotherapy
Y Hu, Q Hu, Y Li, L Lu, Z Xiang, Z Yin… - … and Targeted Therapy, 2023 - nature.com
The intricacy of diseases, shaped by intrinsic processes like immune system exhaustion and
hyperactivation, highlights the potential of immune renormalization as a promising strategy …
hyperactivation, highlights the potential of immune renormalization as a promising strategy …
The role of PD-1 signaling in health and immune-related diseases
RY Chen, Y Zhu, YY Shen, QY Xu, HY Tang… - Frontiers in …, 2023 - frontiersin.org
Programmed cell death 1 receptor (PD-1) and its ligands constitute an inhibitory pathway to
mediate the mechanism of immune tolerance and provide immune homeostasis …
mediate the mechanism of immune tolerance and provide immune homeostasis …
Human inborn errors of immunity: 2022 update on the classification from the international union of immunological societies expert committee
SG Tangye, W Al-Herz, A Bousfiha… - Journal of clinical …, 2022 - Springer
We report the updated classification of inborn errors of immunity, compiled by the
International Union of Immunological Societies Expert Committee. This report documents the …
International Union of Immunological Societies Expert Committee. This report documents the …
PD-L1–PD-1 interactions limit effector regulatory T cell populations at homeostasis and during infection
Phenotypic and transcriptional profiling of regulatory T (Treg) cells at homeostasis reveals
that T cell receptor activation promotes Treg cells with an effector phenotype (eTreg) …
that T cell receptor activation promotes Treg cells with an effector phenotype (eTreg) …
CD5 expression by dendritic cells directs T cell immunity and sustains immunotherapy responses
The induction of proinflammatory T cells by dendritic cell (DC) subtypes is critical for
antitumor responses and effective immune checkpoint blockade (ICB) therapy. Here, we …
antitumor responses and effective immune checkpoint blockade (ICB) therapy. Here, we …
Clinical and translational attributes of immune-related adverse events
KPM Suijkerbuijk, MJM van Eijs, F van Wijk… - Nature Cancer, 2024 - nature.com
With immune checkpoint inhibitors (ICIs) becoming the mainstay of treatment for many
cancers, managing their immune-related adverse events (irAEs) has become an important …
cancers, managing their immune-related adverse events (irAEs) has become an important …
Human OTULIN haploinsufficiency impairs cell-intrinsic immunity to staphylococcal α-toxin
AN Spaan, AL Neehus, E Laplantine, F Staels… - Science, 2022 - science.org
The molecular basis of interindividual clinical variability upon infection with Staphylococcus
aureus is unclear. We describe patients with haploinsufficiency for the linear deubiquitinase …
aureus is unclear. We describe patients with haploinsufficiency for the linear deubiquitinase …
Infections due to dysregulated immunity: an emerging complication of cancer immunotherapy
Immune checkpoint inhibitors (ICIs) have revolutionised cancer treatment. However, immune-
related adverse events (irAEs) are a common side effect which can mimic infection …
related adverse events (irAEs) are a common side effect which can mimic infection …
Learning from the nexus of autoimmunity and cancer
D Mangani, D Yang, AC Anderson - Immunity, 2023 - cell.com
The immune system plays critical roles in both autoimmunity and cancer, diseases at
opposite ends of the immune spectrum. Autoimmunity arises from loss of T cell tolerance …
opposite ends of the immune spectrum. Autoimmunity arises from loss of T cell tolerance …
Genome-wide detection of human intronic AG-gain variants located between splicing branchpoints and canonical splice acceptor sites
Human genetic variants that introduce an AG into the intronic region between the
branchpoint (BP) and the canonical splice acceptor site (ACC) of protein-coding genes can …
branchpoint (BP) and the canonical splice acceptor site (ACC) of protein-coding genes can …